A bi-partisan group from the US Senate Health, Education, Labor and Pensions Committee has issued a draft version of a bill that is designed to bolster the pharmaceutical supply chain. The move comes six months after they released a so-called draft discussion in hopes of gaining a consensus..
As we reported previously, the effort reflects ongoing disagreement over the steps needed to create a system that can thwart distribution of counterfeit or adulterated medicines. A key problem has been a long-standing lack of agreements among drugmakers, wholesalers and pharmacies about an approach.
continue reading here
No comments:
Post a Comment